Search Results - "Paul, Harry"

3D bioengineered tissue model of the large intestine to study inflammatory bowel disease by Roh, Terrence T., Chen, Ying, Paul, Harry T., Guo, Chengchen, Kaplan, David L.

“…An in vitro model of intestinal epithelium with an immune component was bioengineered to mimic immunologic responses seen in inflammatory bowel disease. While…”
Get full text

The Evolution of Gene Expression Plasticity During Adaptation to Salt in Chlamydomonas reinhardtii by Harry-Paul, Yeshoda Y, Lachapelle, Josianne, Ness, Rob W

“…Abstract When environmental change is rapid or unpredictable, phenotypic plasticity can facilitate adaptation to new or stressful environments to promote…”
Get full text

Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection by Frumento, Nicole, Sinnis-Bourozikas, Ariadne, Paul, Harry T, Stavrakis, Georgia, Zahid, Muhammad N, Wang, Shuyi, Ray, Stuart C, Flyak, Andrew I, Shaw, George M, Cox, Andrea L, Bailey, Justin R

“…Individuals who clear primary hepatitis C virus (HCV) infections clear subsequent reinfections more than 80% of the time, but the mechanisms are poorly…”
Get more information

Convergent antibody responses are associated with broad neutralization of hepatitis C virus by Skinner, Nicole E, Ogega, Clinton O, Frumento, Nicole, Clark, Kaitlyn E, Yegnasubramanian, Srinivasan, Schuebel, Kornel, Meyers, Jennifer, Gupta, Anuj, Wheelan, Sarah, Cox, Andrea L, Crowe, Jr, James E, Ray, Stuart C, Bailey, Justin R

“…Early development of broadly neutralizing antibodies (bNAbs) targeting the hepatitis C virus (HCV) envelope glycoprotein E2 is associated with spontaneous…”
Get full text

Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus by Skinner, Nicole E, Ogega, Clinton O, Frumento, Nicole, Clark, Kaitlyn E, Paul, Harry, Yegnasubramanian, Srinivasan, Schuebel, Kornel, Meyers, Jennifer, Gupta, Anuj, Wheelan, Sarah, Cox, Andrea L, Crowe, Jr, James E, Ray, Stuart C, Bailey, Justin R

“…[This corrects the article DOI: 10.3389/fimmu.2023.1135841.]…”
Get full text

Remarks on physics by Paul, Harry

“…I compare and contrast classical and quantum descriptions and then argue that even the celebrated stability of matter following from the Schrödinger equation…”
Get full text

Who Kidnapped Excellence?: What Stops Us from Giving and Being Our Best by Paul, Harry

“…Who Kidnapped Excellence?Most companies talk about excellence, but what does excellence really mean? What specific attitudes and practices lead to excellence?…”
Get full text

Who kidnapped excellence? by Paul, Harry, Britt, John, Jent, Ed

“…Most companies talk about excellence, but what does excellence really mean? What specific attitudes and practices lead to excellence? Drawing on years of study…”
Get full text

Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203 by Raychaudhuri, Suravi, Othus, Megan, Percival, Mary-Elizabeth M., Garcia-Manero, Guillermo, Appelbaum, Frederick R., Erba, Harry Paul, Appelbaum, Jacob

“…6529 Background: Curative-intent therapy for patients with newly diagnosed AML centers on the use of cytarabine as part of an intensive multi-drug induction…”
Get full text

P140 3D BIOENGINEERED TISSUE MODEL OF THE LARGE INTESTINE TO STUDY INFLAMMATORY BOWEL DISEASE by Roh, Terrence, Chen, Ying, Paul, Harry, Guo, Chengchen, Kaplan, David

Get full text

P140 3D BIOENGINEERED TISSUE MODEL OF THE LARGE INTESTINE TO STUDY INFLAMMATORY BOWEL DISEASE by Roh, Terrence, Chen, Ying, Paul, Harry, Guo, Chengchen, Kaplan, David

“…Abstract An in vitro model of intestine epithelium with an immune compartment was bioengineered to mimic immunologic responses seen in inflammatory bowel…”
Get full text

Phase 1 study of ziftomenib (KO-539) in combination with venetoclax or venetoclax/azacitidine or standard induction cytarabine/daunorubicin (7+3) chemotherapy for the treatment of patients with acute myeloid leukemia by Zeidan, Amer Methqal, Fathi, Amir Tahmasb, Issa, Ghayas C., Erba, Harry Paul, Ahsan, Julie, Corum, Daniel, Tomkinson, Blake E., Kozlek, Tom, Leoni, Mollie, Wang, Eunice S.

“…TPS7079 Background: Relapsed or refractory (R/R) acute myeloid leukemia (AML) with nucleophosmin 1-mutations ( NPM1-m) or KMT2A-rearrangment ( KMT2A-r)…”
Get full text

Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry by Erba, Harry Paul, Pollyea, Daniel Aaron, Sekeres, Mikkael A., Garcia-Manero, Guillermo, Seiter, Karen, DeGutis, Irene, Kiselev, Pavel, McBride, Ali, Yu, Edward, Roboz, Gail J.

“…7029 Background: Pts with AML in RCTs often do not reflect the population seen in clinical practice due to strict eligibility criteria. This study evaluated…”
Get full text

George Gale. Dying on the Vine: How Phylloxera Transformed Wine . ix + 323 pp., illus., tables, bibl., index. Berkeley/Los Angeles: University of California Press, 2011. $39.95 (cloth) by Paul, Harry

Get full text

Preliminary results of V-FAST, a phase 1b master trial to investigate CPX-351 combined with targeted agents in newly diagnosed AML by Pullarkat, Vinod, Levis, Mark J., Mannis, Gabriel N., Strickland, Stephen Anthony, Lin, Tara L., Faderl, Stefan, Chakravarthy, Divya, Chandrasekaran, Vijayalakshmi, Cheung, Ronald, Erba, Harry Paul

“…Abstract only 7026 Background: CPX-351 (US: Vyxeos; EU: Vyxeos Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic…”
Get full text

Kusursuz'u kim kaçırdı: En iyiyi yapmamızı ve en iyi olmamızı engelleyen nedir? / Harry Paul, John Britt, Ed Jent ; çeviri, Melis Zeren by Paul, Harry, Britt, John, Jent, Ed, Zeren, Melis

Get more information

V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3 -mutated acute myeloid leukemia by McCloskey, James K., Pullarkat, Vinod A., Mannis, Gabriel N., Lin, Tara L., Strickland, Stephen Anthony, Fathi, Amir Tahmasb, Erba, Harry Paul, Faderl, Stefan, Chakravarthy, Divya, Lutska, Yana, Chandrasekaran, Vijayalakshmi, Cheung, Ronald, Levis, Mark J.

“…7043 Background: CPX-351 (US: Vyxeos; Europe: Vyxeos liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar…”
Get full text

Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance) by Woyach, Jennifer Ann, Yin, Jun, Brown, Jennifer R., Dinner, Shira, Lozanski, Gerard, Little, Richard F., Miller, Cecelia, Damarla, Vijay Kumar, Coutre, Steve E., Ding, Wei, Hill, Brian T, Perez Burbano, Gabriela, Ruppert, Amy S., Wall, Anna K. M., Feldman, Diane, Dib, Elie G., Erba, Harry Paul, Litzow, Mark Robert, Stone, Richard M., Byrd, John C.

“…7500 Background: The Bruton’s tyrosine kinase inhibitor (BTKi) ibrutinib +/- anti-CD20 antibody obinutuzumab (IO) is a standard frontline regimen for older…”
Get full text

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703 by Wieduwilt, Matthew Joseph, Yin, Jun, Kour, Oudom, Teske, Rebecca, Stock, Wendy, Byrd, Kenneth, Doucette, Kimberley, Mangan, James, Masters, Gregory A., Mims, Alice S., Jamieson, Katarzyna, Dinner, Shira Naomi, Bseiso, Ali W., Uy, Geoffrey L., Erba, Harry Paul, Litzow, Mark Robert, Stone, Richard M.

“…7006 Background: Older adult patients (pts) with Philadelphia-chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) have poor survival with…”
Get full text

Phosphoinositide acyl chain saturation drives CD8+ effector T cell signaling and function by Edwards-Hicks, Joy, Apostolova, Petya, Buescher, Joerg M., Maib, Hannes, Stanczak, Michal A., Corrado, Mauro, Klein Geltink, Ramon I., Maccari, Maria Elena, Villa, Matteo, Carrizo, Gustavo E., Sanin, David E., Baixauli, Francesc, Kelly, Beth, Curtis, Jonathan D., Haessler, Fabian, Patterson, Annette, Field, Cameron S., Caputa, George, Kyle, Ryan L., Soballa, Melanie, Cha, Minsun, Paul, Harry, Martin, Jacob, Grzes, Katarzyna M., Flachsmann, Lea, Mitterer, Michael, Zhao, Liang, Winkler, Frances, Rafei-Shamsabadi, David Ali, Meiss, Frank, Bengsch, Bertram, Zeiser, Robert, Puleston, Daniel J., O’Sullivan, David, Pearce, Edward J., Pearce, Erika L.

“…How lipidome changes support CD8 + effector T (T eff ) cell differentiation is not well understood. Here we show that, although naive T cells are rich in…”
Get full text